Monetary Incentives Reduced Some Cannabis Task Deficits Without Removing Dose-Related Impairment

A 1975 study found that monetary incentives were associated with smaller cannabis effects on some tasks, while dose-related impairment remained evident across most of the battery. Motivation and pharmacological tolerance were not the same question.

Motivated and comparison groups were tested

Experienced and previously naive participants smoked placebo and two cannabis dose levels. Their performance across five tasks was compared with matched groups without the monetary incentive. This design examined whether consequences for performance changed the observed drug response.

The benefit was selective

Four of five tasks showed dose-related impairment. Three suggested that motivated participants were less affected than non-motivated participants. The abstract does not establish complete restoration, and an incentive effect in some tasks should not be expanded to every cognitive function.

Experience did not provide the expected group advantage

The study found no difference between naive and experienced participants in the reported performance comparison. That null result does not establish that use history never matters, but it prevents attributing this experiment's incentive-related differences to demonstrated user tolerance.

The findings show that effort, incentives and drug effects can jointly influence a test score. Better performance under incentive does not prove the drug has stopped acting or establish fitness for driving. The relevant assessment should identify the task, dose and conditions motivating the participant.

Related: interpreting cannabis tolerance claims.

Research cited

Casswell S. Cannabis intoxication: effects of monetary incentive on performance, a controlled investigation of behavioural tolerance in moderate users of cannabis. Perceptual and motor skills (1975). doi:10.2466/pms.1975.41.2.423. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A Psychiatric CBD Review’s Recommendation Grades Included Both CBD and THC-Containing Nabiximols

A review published in 2020 graded psychiatric evidence from studies of CBD and CBD-containing nabiximols. Its recommendation labels should not be quoted as though every underlying intervention was purified CBD or every study was randomized. The included designs ranged widely The review identified 23 relevant studies spanning case reports, case…

Spread the love

Read Article: A Psychiatric CBD Review’s Recommendation Grades Included Both CBD and THC-Containing Nabiximols

CBD Eye Research: Molecular Targets and Clinical Ocular Treatment Are Different Evidence Levels

A 2021 ocular CBD review brought together in-vitro and in-vivo research, proposed molecular targets and possible therapeutic applications. This evidence maps a development pathway; it does not establish that CBD products are effective eye treatments. The experimental system belongs in the conclusion A cellular result can identify a target or…

Spread the love

Read Article: CBD Eye Research: Molecular Targets and Clinical Ocular Treatment Are Different Evidence Levels

CBD Addiction Research Measures Reinforcement, Motivation and Withdrawal as Different Outcomes

A 2021 review evaluated CBD research on reinforcing, motivational and withdrawal-related drug effects. These outcomes can inform substance-use-disorder research, but an improvement in one cannot establish successful treatment across all of them. The source combined preclinical and clinical reports The review covered alcohol, opioids, cannabinoids, nicotine and psychostimulants. An animal…

Spread the love

Read Article: CBD Addiction Research Measures Reinforcement, Motivation and Withdrawal as Different Outcomes

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us